Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nuwellis Inc NUWE

Healthcare Medical Devices
Nuwellis, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms... see more

Recent & Breaking News (NDAQ:NUWE)

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

GlobeNewswire 12 days ago

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

GlobeNewswire November 5, 2024

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

GlobeNewswire November 4, 2024

Nuwellis Announces Preliminary Results for Third Quarter of 2024

GlobeNewswire November 1, 2024

Nuwellis Welcomes University of Iowa Health Care Stead Family Children's Hospital as Newest Pediatric Customer

GlobeNewswire October 31, 2024

Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024

GlobeNewswire October 23, 2024

Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference

GlobeNewswire September 25, 2024

New Study Published in Current Problems in Cardiology Highlights Statistically Significant Reduction in Heart Failure Readmissions at 60 days when using the Aquadex Ultrafiltration Therapy

GlobeNewswire August 27, 2024

Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire August 23, 2024

Nuwellis, Inc. Announces Second Quarter 2024 Financial Results

GlobeNewswire August 13, 2024

Nasdaq Panel Grants Nuwellis Continued Listing on the Nasdaq Stock Market, Subject to Conditions

GlobeNewswire August 8, 2024

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical's QUELIMMUNE(TM) Therapy at Cincinnati Children's

GlobeNewswire July 26, 2024

Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire July 24, 2024

Nuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024

GlobeNewswire July 23, 2024

Nuwellis Marks First Commercial Sale of QUELIMMUNE(TM) Therapy to Cincinnati Children's

GlobeNewswire July 17, 2024

SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner

GlobeNewswire July 12, 2024

New Evidence on Aquadex Ultrafiltration Therapy to be Presented at HFSA 2024 Conference

GlobeNewswire July 9, 2024

Nuwellis Announces Reverse Stock Split

GlobeNewswire June 26, 2024

Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian(TM)

GlobeNewswire June 25, 2024

Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase

GlobeNewswire June 6, 2024